Title : Dimethyl Fumarate Combined With Vemurafenib Enhances Anti-Melanoma Efficacy via Inhibiting the Hippo/YAP, NRF2-ARE, and AKT/mTOR/ERK Pathways in A375 Melanoma Cells.

Pub. Date : 2022

PMID : 35141161






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Dimethyl Fumarate Combined With Vemurafenib Enhances Anti-Melanoma Efficacy via Inhibiting the Hippo/YAP, NRF2-ARE, and AKT/mTOR/ERK Pathways in A375 Melanoma Cells. Dimethyl Fumarate AKT serine/threonine kinase 1 Homo sapiens